Synthesis and in vitro anti-HIV activity of N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives using MTT method

LODDO, ROBERTA;
2011-01-01

Abstract

A series of novel N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives has been synthesized. All the newly synthesized compounds were evaluated for their anti-HIV activity using MTT method. Most of these compounds showed moderate to potent activity against wild-type HIV-1 with an EC(50) ranging from >7 EC(50) [μg/ml] to <100 EC(50) [μg/ml]. Among them, N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide 6v was identified as the most promising compound (EC(50)=<7 μg/ml). Among all the compounds, three compounds 6m, 6v and 6u have been exhibits potent anti-HIV activity against MT-4 cells.
2011
Inglese
21
11
3443
3446
4
http://dx.doi.org/10.1016/j.bmcl.2011.03.105
Esperti anonimi
internazionale
scientifica
Benzothiazole chromene derivatives; Anti-HIV activity; MT-4 cells; MTT method
Bhavsar, D; Trivedi, J; Parekh, S; Savant, M; Thakrar, S; Bavishi, A; Radadiya, A; Vala, H; Lunagariya, J; Parmar, M; Paresh, L; Loddo, Roberta; Shah, ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
13
reserved
File in questo prodotto:
File Dimensione Formato  
2011 3443-3446.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 268.3 kB
Formato Adobe PDF
268.3 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Questionario e social

Condividi su:
Impostazioni cookie